Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03568851 · ClinicalTrials.gov registry record
Reproductive Health Outcomes by Method of Breast Milk Feeding
A clinical trial, sponsored by University of California, Davis.
- Completed
- Registry status
- 394
- Enrollment target
NCT03568851: Completed study, sponsored by University of California, Davis.
NCT03568851 is a clinical trial that has completed, run by University of California, Davis. The registered enrollment target is 394 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03568851 has completed, sponsored by University of California, Davis.
- COMPLETED
- Registry status
- 394 participants
- Enrollment target
Study Summary
The purpose of this research is to determine whether there are differences in ovarian suppression between women who are feeding at the breast compared with women who are pumping. * In the main study, the aim is to compare reproductive health outcomes, including amenorrhea rates, duration of lactation, and resumption of sexual activity, between mothers who are exclusively breastfeeding (i.e. feeding at the breast) and those who are pumping after a term or preterm delivery. * In the sub-study, the aim is to determine the feasibility and acceptability of using urinary luteinizing hormone (LH) detection kits at home to detect ovulation in exclusively breastmilk feeding women.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 394 participants |
| Start Date | 2018-06-27 |
| Est. Completion | 2021-01-14 |
What the finished NCT03568851 record still lists
NCT03568851 is an observational study that tracks outcomes without assigning an intervention. The registered 394 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT03568851 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03568851 about?
NCT03568851 is a clinical study titled "Reproductive Health Outcomes by Method of Breast Milk Feeding". The purpose of this research is to determine whether there are differences in ovarian suppression between women who are feeding at the breast compared with women who are pumping. * In the main study, the aim is to compare reproductive health outcomes, including amenorrhea rates, duration of lactati...
What is the current status of trial NCT03568851?
This trial is currently completed. The enrollment target is 394 participants. The study started on 2018-06-27. Estimated completion is 2021-01-14.
Who is sponsoring clinical trial NCT03568851?
This trial is sponsored by University of California, Davis, which has 657 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06657924 · 394 participants · Phase 2
Preoperative Tranexamic Acid (TXA) to Prevent Bleeding in Patients Undergoing Major Colorectal Surgery
- NCT07225660 · 394 participants · NA
Hormonal Optimization: Late vs. Immediate Start After Discontinuation of Oral Contraceptives in Assisted Reproductive technologY (HOLIDAY)
- NCT07207369 · 395 participants · Phase 3
A Study to Assess the Safety and Effectiveness of ELAPR002f Injectable Gel in Adult Participants With Atrophic Acne Scars
- NCT05640999 · 393 participants · Phase 2
Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI